Search Results

New research suggests a small group of pediatric brain tumor patients may benefit from immunotherapy.

SARS-CoV-2 may dramatically impair the immune response by reprogramming neutrophils resulting in severe covid.

Researchers develop antibody therapy to target cancer by focusing on the tumour environment, showing promise for wider cancer treatment applications

Afami-cel Phase I trial shows noteworthy responses in synovial sarcoma

The first-generation SNORCL is capable of producing short and modest pulses of oxygen inside cells in response to added chlorite.

Each year about 1.5 million people in the U.S. survive a traumatic brain injury due to a fall, car accident, or a sports injury, which can cause immediate and long-term disability.